pharmatechoutlook
APRIL 20245TECH OUTLOOKCXO INSIGHTSCXO INSIGHTSPG - 28LAST WORD30On Accelerating Bioanalytical Workflow AutomationMing Li, Director,Bioanalytical and Biomarker Outsourcing Operations,Alexion PharmaceuticalsRe-Thinking The Pharmaceutical Value ChainIvanna M. Rosendal, Senior Director, IT Business Partner, Ascendis Pharma18Cleaning Validation Increasingly under Regulatory SpotlightMirian Janett Alvarez,QMC Puerto Rico Director,PharmaLex20How a Quality Improvement Plan Can Enhance Quality MaturityJennifer Vavala, Senior Director Quality Assurance, Ajinomoto Bio-Pharma Services24Quality Assurance: Navigating the Escalating Compliance ComplexitiesImelda Rillon,Director, Regional Quality Assurance,Zuellig Pharma25Historical control in gene therapy clinical developmentHaichen Yang, MD, MA, MBA, Vice President, Clinical Research, Amicus Therapeutics Inc26Significance of GMPs in Pharmaceutical ManufacturingRobert Zanon,General Manager - Quality,Probiotec22Rapid Release Quality Control Solution for Cellular TherapiesJon Kallay,SeniorTechnology andMarket Development Manager,Charles River Laboratories17TOP 10TECH OUTLOOKPHARMACEUTICALQUALITY ASSURANCESOLUTIONS PROVIDERS IN APAC - 2024
< Page 4 | Page 6 >